Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 2/2023

07.01.2023 | Original Article

Histological evaluation of vascular changes after excimer laser angioplasty for neointimal formation after bare-metal stent implantation in rabbit iliac arteries

verfasst von: Hirofumi Nagamatsu, Sho Torii, Kazuki Aihara, Keigo Nakazawa, Norihito Nakamura, Satoshi Noda, Satsuki Sekino, Fuminobu Yoshimachi, Gaku Nakazawa, Yuji Ikari

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Excimer laser is used to treat coronary artery disease, especially in case of lesions with thrombus and in-stent restenosis (ISR). However, there are no in vivo preclinical studies that have evaluated the pathological reactions of the vessel wall after excimer laser ablation.

Methods

Bare-metal stents were placed in the external iliac arteries of six healthy rabbits. Twenty-eight days later, excimer laser ablation was performed with low-power (45 (fluency)/25 (rate)) in one side, and high-power (60/40) in the opposite side, followed by optical coherence tomography (OCT) evaluation. Rabbits were sacrificed 15 min after the procedure, and histological assessment was performed.

Results

Morphometry analysis of OCT showed similar stent and lumen size between low-power and high-power group. Histological evaluation suggested endothelial cell loss, fibrin deposition, and tissue loss. The low-power group showed significantly less pathological changes compared with the high-power group: angle of endothelial cell loss, 32.4° vs. 191.7° (interquartile range, 8.8°–131.7° vs. 125.7°–279.5°; p < 0.01); fibrin deposition, 1.1° vs. 59.6° (0.0°–70.4° vs. 31.4°–178.4°; p = 0.03); and tissue loss 0.0° vs. 18.2° (0.0°–8.7° vs. 0.0°–42.7°; p = 0.03).

Conclusions

The pathological changes in neointima were more prominent after high-power excimer laser ablation than after low-power excimer laser. To improve safety in clinical practice, understanding the pathological changes of tissues after excimer laser in lesions with ISR is essential.
Literatur
1.
Zurück zum Zitat Cook SL, Eigler NL, Shefer A, Goldenberg T, Forrester JS, Litvack F. Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation. 1991;84:632–43.CrossRefPubMed Cook SL, Eigler NL, Shefer A, Goldenberg T, Forrester JS, Litvack F. Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation. 1991;84:632–43.CrossRefPubMed
2.
Zurück zum Zitat Rawlins J, Din JN, Talwar S, O’Kane P. Coronary intervention with the excimer laser: review of the technology and outcome data. Interv Cardiol. 2016;11:27–32.CrossRefPubMedPubMedCentral Rawlins J, Din JN, Talwar S, O’Kane P. Coronary intervention with the excimer laser: review of the technology and outcome data. Interv Cardiol. 2016;11:27–32.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Tsutsui RS, Sammour Y, Kalra A, et al. Excimer laser atherectomy in percutaneous coronary intervention: a contemporary review. Cardiovasc Revasc Med. 2021;25:75–85.CrossRefPubMed Tsutsui RS, Sammour Y, Kalra A, et al. Excimer laser atherectomy in percutaneous coronary intervention: a contemporary review. Cardiovasc Revasc Med. 2021;25:75–85.CrossRefPubMed
4.
Zurück zum Zitat Dahm JB, Topaz O, Woenckhaus C, et al. Laser-facilitated thrombectomy: a new therapeutic option for treatment of thrombus-laden coronary lesions. Catheter Cardiovasc Interv. 2002;56:365–72.CrossRefPubMed Dahm JB, Topaz O, Woenckhaus C, et al. Laser-facilitated thrombectomy: a new therapeutic option for treatment of thrombus-laden coronary lesions. Catheter Cardiovasc Interv. 2002;56:365–72.CrossRefPubMed
5.
Zurück zum Zitat Topaz O, Bernardo NL, Shah R, et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol. 2001;87:849–55.CrossRefPubMed Topaz O, Bernardo NL, Shah R, et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol. 2001;87:849–55.CrossRefPubMed
6.
7.
Zurück zum Zitat Sintek M, Coverstone E, Bach R, et al. Excimer laser coronary angioplasty in coronary lesions: use and safety from the NCDR/CATH PCI registry. Circ Cardiovasc Interv. 2021;14:e010061.CrossRefPubMed Sintek M, Coverstone E, Bach R, et al. Excimer laser coronary angioplasty in coronary lesions: use and safety from the NCDR/CATH PCI registry. Circ Cardiovasc Interv. 2021;14:e010061.CrossRefPubMed
8.
Zurück zum Zitat Nakazawa G, Torii S, Ijichi T et al. Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model. J Ame Heart Assoc 2016;5. Nakazawa G, Torii S, Ijichi T et al. Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model. J Ame Heart Assoc 2016;5.
9.
Zurück zum Zitat Fujihara M, Kurata N, Yazu Y, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597–612.CrossRefPubMed Fujihara M, Kurata N, Yazu Y, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597–612.CrossRefPubMed
10.
Zurück zum Zitat Fujii K, Kubo T, Otake H, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. Cardiovasc Interv Ther. 2022;37:248–54.CrossRefPubMed Fujii K, Kubo T, Otake H, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022. Cardiovasc Interv Ther. 2022;37:248–54.CrossRefPubMed
11.
Zurück zum Zitat Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Ohno Y, Ikari Y. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther. 2018;33:55–61.CrossRefPubMed Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Ohno Y, Ikari Y. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther. 2018;33:55–61.CrossRefPubMed
12.
Zurück zum Zitat Torii S, Yahagi K, Mori H, et al. Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries. J Vasc Interv Radiol. 2018;29:1041-1049.e3.CrossRefPubMed Torii S, Yahagi K, Mori H, et al. Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries. J Vasc Interv Radiol. 2018;29:1041-1049.e3.CrossRefPubMed
13.
Zurück zum Zitat Torii S, Yahagi K, Mori H, et al. Safety of zilver PTX drug-eluting stent implantation following drug-coated balloon dilation in a healthy swine model. J Endovasc Ther. 2018;25:118–26.CrossRefPubMed Torii S, Yahagi K, Mori H, et al. Safety of zilver PTX drug-eluting stent implantation following drug-coated balloon dilation in a healthy swine model. J Endovasc Ther. 2018;25:118–26.CrossRefPubMed
14.
Zurück zum Zitat Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol. 2020;17:37–51.CrossRefPubMed Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol. 2020;17:37–51.CrossRefPubMed
15.
Zurück zum Zitat Giacoppo D, Alfonso F, Xu B, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75:2664–78.CrossRefPubMed Giacoppo D, Alfonso F, Xu B, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75:2664–78.CrossRefPubMed
16.
Zurück zum Zitat Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694–701.CrossRefPubMed
17.
Zurück zum Zitat Nishino M, Mori N, Takiuchi S, et al. Indications and outcomes of excimer laser coronary atherectomy: efficacy and safety for thrombotic lesions—the ULTRAMAN registry. J Cardiol. 2017;69:314–9.CrossRefPubMed Nishino M, Mori N, Takiuchi S, et al. Indications and outcomes of excimer laser coronary atherectomy: efficacy and safety for thrombotic lesions—the ULTRAMAN registry. J Cardiol. 2017;69:314–9.CrossRefPubMed
Metadaten
Titel
Histological evaluation of vascular changes after excimer laser angioplasty for neointimal formation after bare-metal stent implantation in rabbit iliac arteries
verfasst von
Hirofumi Nagamatsu
Sho Torii
Kazuki Aihara
Keigo Nakazawa
Norihito Nakamura
Satoshi Noda
Satsuki Sekino
Fuminobu Yoshimachi
Gaku Nakazawa
Yuji Ikari
Publikationsdatum
07.01.2023
Verlag
Springer Nature Singapore
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 2/2023
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-022-00905-8

Weitere Artikel der Ausgabe 2/2023

Cardiovascular Intervention and Therapeutics 2/2023 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.